Drawing for AUTOSYNVAX

USPTO serial 88693944

AUTOSYNVAX

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
PARKER, JUSTINE D
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AUTOSYNVAX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christina M. Licursi

Christina M. Licursi WOLF, GREENFIELD & SACKS, P.C.600 ATLANTIC AVENUEBOSTON, MA 02210-2206UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and biopharmaceutical agents, namely, vaccines, immunotherapeutics, and other therapeutic agents, for the prevention and treatment of human diseases, namely, cancers, autoimmune disorders, infectious disease, transplant rejectionACTIVE—
016Printed matter, namely, monographs and selling aids in the nature of brochures, manuals, pamphlets, leaflets and charts in the fields of medicines, medical therapies and patient educationACTIVE—
042Research and development of vaccines, immunotherapeutics, and other therapeutic agentsACTIVE—
044Medical, pharmaceutical and health care services, namely, providing information and advice to patients and health care professionals regarding the use of pharmaceutical agents and biopharmaceutical agents, including vaccines, immunotherapeutics, and other therapeutic agents, for the prevention or treatment of human diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 20, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 19, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 30, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 29, 2022EX5GSOU EXTENSION 5 GRANTED—
Nov 29, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 16, 2022EXT5SOU EXTENSION 5 FILED—
Nov 16, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 7, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 5, 2022EX4GSOU EXTENSION 4 GRANTED—
May 5, 2022EXT4SOU EXTENSION 4 FILED—
May 5, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 19, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 17, 2021EX3GSOU EXTENSION 3 GRANTED—
Nov 17, 2021EXT3SOU EXTENSION 3 FILED—
Nov 17, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 8, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 6, 2021EX2GSOU EXTENSION 2 GRANTED—
May 6, 2021EXT2SOU EXTENSION 2 FILED—
May 6, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 20, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 18, 2020EX1GSOU EXTENSION 1 GRANTED—
Nov 18, 2020EXT1SOU EXTENSION 1 FILED—
Nov 18, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 19, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 24, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 24, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 4, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 20, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 20, 2020DOCKASSIGNED TO EXAMINER—
Nov 21, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 19, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance